本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Can-Fite Biopharma Ltd

2.33
+0.17007.87%
盤後2.330.00000.00%19:54 EDT
成交量:15.50萬
成交額:35.41萬
市值:499.21萬
市盈率:-0.50
高:2.37
開:2.17
低:2.16
收:2.16
52周最高:13.40
52周最低:2.16
股本:214.25萬
流通股本:214.25萬
量比:0.95
換手率:7.23%
股息:- -
股息率:- -
每股收益(TTM):-4.6460
每股收益(LYR):-1,791.0249
淨資產收益率:-211.37%
總資產收益率:-77.12%
市淨率:1.03
市盈率(LYR):0.00

資料載入中...

2020/04/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/06

SEC問詢函

CORRESP [Cover] - Correspondence
2020/04/06

SEC問詢函

CORRESP [Cover] - Correspondence
2020/04/02

非美公司披露報告

6-K/A [Amend] - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/27

招股説明書

F-1 - Registration statement for certain foreign private issuers
2020/03/27

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/27

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/20

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]